BC PharmaCare - Review of medications for COPD

Issued February 27, 2019 - Deadline March 27, 2019

The drugs included in this review are

• Aclidinium bromide (TUDORZA® GENUAIR®), by AstraZeneca Canada Inc.

• Aclidinium bromide-formoterol fumarate (DUAKLIR® GENUAIR®), by AstraZeneca Canada Inc.

• Beclomethasone dipropionate (QVAR™), by Valeant Canada LP

• Budesonide (PULMICORT® TURBUHALER®), by AstraZeneca Canada Inc.

• Budesonide-formoterol fumarate (SYMBICORT® TURBUHALER®), by AstraZeneca Canada

• Ciclesonide (ALVESCO®), by AstraZeneca Canada Inc.

• Fluticasone furoate (ARNUITY ELLIPTA), by GlaxoSmithKline Inc.(GSK)

• Fluticasone furoate-vilanterol (BREO ELLIPTA), by GlaxoSmithKline Inc.

• Fluticasone furoate-umeclidinium-vilanterol (TRELEGY ELLIPTA), by GlaxoSmithKline Inc.

• Fluticasone propionate (FLOVENT HFA and FLOVENT DISKUS) by GSK Inc. and (AERMONY RESPICLICKTM) by Teva Canada

• Fluticasone propionate-salmeterol (ADVAIR, ADVAIR DISKUS) by GSK Inc. and (ARBESDA RESPICLICKTM) by Teva Canada 

• Formoterol fumarate (FORADIL) by Novartis Pharmaceuticals Canada Inc. and (OXEZE® TURBUHALER®) by AstraZeneca Canada Inc.

• Glycopyrronium bromide (SEEBRI® BREEZHALER®), by Novartis Pharmaceuticals Canada Inc.

• Indacaterol maleate (ONBREZ® BREEZHALER®), by Novartis Pharmaceuticals Canada Inc.

• Indacaterol-glycopyrronium (ULTIBRO® BREEZHALER®), by Novartis Pharmaceuticals Canada

• Mometasone furoate (ASMANEX® TWISTHALER®), by Merck Canada Inc.

• Mometasone furoate-formoterol (ZENHALE®), by Merck Canada Inc.

• Salmeterol xinafoate (SEREVENT® DISKHALER® and SEREVENT® DISKUS®), by GlaxoSmithKline Inc.

• Tiotropium (SPIRIVA® and SPIRIVA® RESPIMAT®), by Boehringer Ingelheim Canada Ltd.

• Tiotropium-olodaterol (INSPIOLTO™ RESPIMAT®), by Boehringer Ingelheim (Canada) Ltd.

• Umeclidinium (INCRUSE ELLIPTA), by GlaxoSmithKline Inc.

• Umeclidinium-vilanterol (ANORO ELLIPTA), by GlaxoSmithKline Inc


To receive the complete document from BC PharmaCare click on the image below: